An expert panel has been put together by the American Society of Clinical Oncology (ASCO) which involves professionals from a variety of areas in the brain cancer research field. Their aim was to determine an updated set of guidelines to govern the treatment of cancer that has spread to the brain, hopefully improving the outcomes and quality of life for brain metastases patients in the future.
How have the guidelines changed?
In the past, the guidelines for this kind of cancer treatment have focussed on the use of both steroids and radiation to the entirety of the brain.
Now, the guidelines are much more evidence based and utilise data collected from numerous controlled and randomised studies to guide how surgery and chemotherapy should be used. With this new approach, the outcomes for patients are expected to improve – Just as they have in the past with other subsets of the community, as a result of the more encompassing and informed guidance.
You can read more about the guidelines on the Journal of Clinical Oncology website.
Do you have experience with brain metastases?
brainstrust is working with researchers to improve the outcomes for patients with brain metastases, too. If you or someone you know has experience with cancer that has spread to the brain, consider helping us to support current research by filling out a survey designed by Neuro-Oncologist Rasheed Zakaria to collect feedback on when is best to utilise radiotherapy in brain metastases treatment.
If you would like to use your experience and insight to support clinical research, consider signing up to be a PRIME advocate for brainstrust.
If you or someone you love is living with a brain tumour and have any questions around this latest news, or want to access support, give us a call on 01983 292 405 or email email@example.com. You can also visit our little brainstrust website which features support for children affected by brain tumour.